Related Experiment Video
Updated: Mar 29, 2026

Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation
Published on: December 15, 2017
Serum-Inert Tandem-Locked Fluorescent Probe for Specific Imaging of Intratumoral Complement System
Yuxuan Hu1, Jiayan Wu1, Kanyi Pu1,2
1School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, Singapore, Singapore.
Researchers developed a novel fluorescence probe to track complement system activity within tumors. This tool allows real-time imaging and profiling of complement proteins, offering new insights into the tumor immune microenvironment and potential diagnostic applications.
Area of Science:
- Biomedical Engineering
- Molecular Imaging
- Cancer Biology
Background:
- The complement system plays a role in cancer, but its dynamic behavior in tumors is poorly understood due to limitations of conventional analytical methods.
- Real-time imaging of intratumoral complement activity is challenging due to serum protein interference and lack of specific probes.
- Understanding complement system dynamics is crucial for deciphering the tumor immune microenvironment.
Purpose of the Study:
- To develop a novel molecular optical probe for non-invasive, real-time monitoring of intratumoral complement system activity.
- To overcome challenges associated with serum complement protein interference and nonspecific probe activation.
- To investigate the role of complement activity in different tumor models and its correlation with immune cell infiltration.
Main Methods:
- Synthesis of a tandem-locked fluorescence probe (TECPCTSB) with high C1r specificity and a cathepsin B (CTSB)-cleavable masking sequence.
- Screening of peptide sequences for enzymatic kinetics toward C1r and CTSB.
- In vivo imaging of intratumoral complement activity in 4T1 and CT26 tumor models.
- Flow cytometry profiling of complement activation-associated fluorescence in tumor tissues.
Main Results:
- The developed probe TECPCTSB selectively detects intratumoral complement activity without nonspecific activation in circulation.
- Higher intratumoral complement activity was observed in 4T1 tumors compared to CT26 tumors, potentially explaining differences in myeloid-derived suppressor cell infiltration.
- Complement activation-associated fluorescence was primarily detected in cancer-associated fibroblasts and tumor cells, often localized at the tumor periphery.
- Chemotherapy treatment led to enhanced complement activation extending into the tumor interior.
Conclusions:
- The novel fluorescence probe enables unprecedented in vivo imaging and flow cytometry analysis of intratumoral complement activity.
- Findings provide new insights into the differential roles of complement in various tumor types and their immunosuppressive microenvironments.
- The probe holds significant potential for complement system research, cancer diagnostics, and monitoring therapeutic responses.
More Related Videos
12:24Computed Tomography-guided Time-domain Diffuse Fluorescence Tomography in Small Animals for Localization of Cancer Biomarkers
Published on: July 17, 2012
09:34Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022